[Clinical significance of minimal residual disease in patients with Ph-negative precursor B-acute lymphoblastic leukemia].

Liu, K Q; Wei, H; Lin, D; Wang, Y; Zhou, C L; Liu, B C; Li, X L; Zhao, Y; Li, H J; Wang, C W; Li, Q H; Li, B F; Gong, Y T; Liu, X Y; Gong, Y C; Mi, J X; Wang, Jianxiang

Liu, K Q; Wei, H; Lin, D; Wang, Y; Zhou, C L; Liu, B C; Li, X L; Zhao, Y; Li, H J; Wang, C W; Li, Q H; Li, B F; Gong, Y T; Liu, X Y; Gong, Y C; Mi, J X; Wang, Jianxiang.

Afiliação

Liu KQ; Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.

Zhonghua Xue Ye Xue Za Zhi ; 39(9): 724-728, 2018 Sep 14.

Article em Zh | MEDLINE | ID: mdl-30369181

Assuntos

Leucemia-Linfoma Linfoblástico de Células Precursoras; Citometria de Fluxo; Humanos; Neoplasia Residual; Prognóstico; Recidiva

Palavras-chave

Flow Cytometry; Leukemia, lymphoblastic; Minimal residual disease; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google